SoGanja

In September 2026, SoGanja concentrated 55.22% of sales in Beverage while Flower accounted for 20.18%, with Pre-Roll at 13.42% and Concentrates at 11.18%; within that mix, Beverage declined month over month by 19.64% even as it inched up year over year by 28.42%, whereas Pre-Roll surged month over month by 48.15% and expanded year over year by 32,316.18%. Flower contracted month over month by 15.65% (year-over-year data unavailable), and Concentrates dipped month over month by 7.92% alongside a 32.53% year-over-year lift, and SoGanja held rank 5 in Beverage in Missouri; the pattern indicates a pivot underway from a Beverage-led portfolio toward faster-turning inhalables as price points diverge, with average brand pricing up 39.82% year over year against a Beverage average price of $15.67.

These shifts imply SoGanja’s positioning is migrating toward value-accessible entry points in Pre-Roll (13.42% share) and premiumized Flower (20.18% share) as the Beverage anchor softens month over month by 19.64% while the brand’s overall sales rose year over year by 50.94%; holding rank 5 in Beverage in Missouri alongside a 48.15% month-over-month Pre-Roll lift sets a two-pronged path where inhalables absorb near-term volume while Beverage maintains category credibility. With Concentrates adding a 32.53% year-over-year gain but slipping 7.92% month over month and average brand price at $20.04, the mix suggests SoGanja can trade consumers up within inhalables while using Beverage presence to retain discovery traffic, signaling a need to rebalance promotional cadence toward Pre-Roll velocity without eroding the Beverage rank position.